BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31736268)

  • 1. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC.
    Liu Y; Yang Y; Zhang L; Lin J; Li B; Yang M; Li H; Chen K; Zhao W
    Cancer Cell Int; 2021 Oct; 21(1):572. PubMed ID: 34715859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
    Jin J; Chu Z; Ma P; Meng Y; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
    Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
    Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer.
    Cao S; Lin L; Xia X; Wu H
    Mol Ther Nucleic Acids; 2019 Sep; 17():455-464. PubMed ID: 31330497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
    J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
    Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
    Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
    Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
    Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
    Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
    Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
    Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
    J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
    Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B
    Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.